table of content
1 Human Growth Hormone Drugs Market Overview
1.1 Product Overview and Scope of Human Growth Hormone Drugs
1.2 Human Growth Hormone Drugs Segment by Type
1.2.1 Global Human Growth Hormone Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Human Growth Hormone Drugs Segment by Application
1.3.1 Global Human Growth Hormone Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Global Human Growth Hormone Drugs Market Size Estimates and Forecasts
1.4.1 Global Human Growth Hormone Drugs Revenue 2017-2028
1.4.2 Global Human Growth Hormone Drugs Sales 2017-2028
1.4.3 Human Growth Hormone Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Human Growth Hormone Drugs Market Competition by Manufacturers
2.1 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Human Growth Hormone Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Human Growth Hormone Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Human Growth Hormone Drugs Manufacturing Sites, Area Served, Product Type
2.5 Human Growth Hormone Drugs Market Competitive Situation and Trends
2.5.1 Human Growth Hormone Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Growth Hormone Drugs Players Market Share by Revenue
2.5.3 Global Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Growth Hormone Drugs Retrospective Market Scenario by Region
3.1 Global Human Growth Hormone Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Human Growth Hormone Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Human Growth Hormone Drugs Market Facts & Figures by Country
3.3.1 North America Human Growth Hormone Drugs Sales by Country
3.3.2 North America Human Growth Hormone Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Growth Hormone Drugs Market Facts & Figures by Country
3.4.1 Europe Human Growth Hormone Drugs Sales by Country
3.4.2 Europe Human Growth Hormone Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Human Growth Hormone Drugs Sales by Region
3.5.2 Asia Pacific Human Growth Hormone Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Growth Hormone Drugs Market Facts & Figures by Country
3.6.1 Latin America Human Growth Hormone Drugs Sales by Country
3.6.2 Latin America Human Growth Hormone Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country
3.7.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Human Growth Hormone Drugs Historic Market Analysis by Type
4.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
4.2 Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Human Growth Hormone Drugs Price by Type (2017-2022)
5 Global Human Growth Hormone Drugs Historic Market Analysis by Application
5.1 Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
5.2 Global Human Growth Hormone Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Human Growth Hormone Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Eli Lilly and Company (US)
6.1.1 Eli Lilly and Company (US) Corporation Information
6.1.2 Eli Lilly and Company (US) Description and Business Overview
6.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio
6.1.5 Eli Lilly and Company (US) Recent Developments/Updates
6.2 Ferring Holding SA (Switzerland)
6.2.1 Ferring Holding SA (Switzerland) Corporation Information
6.2.2 Ferring Holding SA (Switzerland) Description and Business Overview
6.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio
6.2.5 Ferring Holding SA (Switzerland) Recent Developments/Updates
6.3 Genentech, Inc. (US)
6.3.1 Genentech, Inc. (US) Corporation Information
6.3.2 Genentech, Inc. (US) Description and Business Overview
6.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio
6.3.5 Genentech, Inc. (US) Recent Developments/Updates
6.4 GeneScience Pharmaceuticals Co., Ltd. (China)
6.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
6.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Description and Business Overview
6.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio
6.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments/Updates
6.5 Merck KgaA (Germany)
6.5.1 Merck KgaA (Germany) Corporation Information
6.5.2 Merck KgaA (Germany) Description and Business Overview
6.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio
6.5.5 Merck KgaA (Germany) Recent Developments/Updates
6.6 Novo Nordisk A/S (Denmark)
6.6.1 Novo Nordisk A/S (Denmark) Corporation Information
6.6.2 Novo Nordisk A/S (Denmark) Description and Business Overview
6.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio
6.6.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates
6.7 Pfizer, Inc. (US)
6.6.1 Pfizer, Inc. (US) Corporation Information
6.6.2 Pfizer, Inc. (US) Description and Business Overview
6.6.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio
6.7.5 Pfizer, Inc. (US) Recent Developments/Updates
6.8 Sandoz International GmbH (Germany)
6.8.1 Sandoz International GmbH (Germany) Corporation Information
6.8.2 Sandoz International GmbH (Germany) Description and Business Overview
6.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio
6.8.5 Sandoz International GmbH (Germany) Recent Developments/Updates
7 Human Growth Hormone Drugs Manufacturing Cost Analysis
7.1 Human Growth Hormone Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Growth Hormone Drugs
7.4 Human Growth Hormone Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Growth Hormone Drugs Distributors List
8.3 Human Growth Hormone Drugs Customers
9 Human Growth Hormone Drugs Market Dynamics
9.1 Human Growth Hormone Drugs Industry Trends
9.2 Human Growth Hormone Drugs Market Drivers
9.3 Human Growth Hormone Drugs Market Challenges
9.4 Human Growth Hormone Drugs Market Restraints
10 Global Market Forecast
10.1 Human Growth Hormone Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Growth Hormone Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Human Growth Hormone Drugs by Type (2023-2028)
10.2 Human Growth Hormone Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Growth Hormone Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Human Growth Hormone Drugs by Application (2023-2028)
10.3 Human Growth Hormone Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Growth Hormone Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Human Growth Hormone Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
